These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 21191718)
1. Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Byun YJ; Lee SJ; Koh HJ Jpn J Ophthalmol; 2010 Nov; 54(6):571-7. PubMed ID: 21191718 [TBL] [Abstract][Full Text] [Related]
2. Intravitreal triamcinolone, bevacizumab and pegaptanib for occult choroidal neovascularization. Forte R; Cennamo G; Finelli M; Cesarano I; D'Amico G; De Crecchio G; Cennamo G Acta Ophthalmol; 2010 Dec; 88(8):e305-10. PubMed ID: 20946332 [TBL] [Abstract][Full Text] [Related]
3. A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations. Algvere PV; Steén B; Seregard S; Kvanta A Acta Ophthalmol; 2008 Aug; 86(5):482-9. PubMed ID: 18162062 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration. Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A Retina; 2007; 27(4):432-8. PubMed ID: 17420694 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration in treatment-naive patients. Pedersen KB; Sjølie AK; Møller F Acta Ophthalmol; 2009 Nov; 87(7):714-9. PubMed ID: 19094171 [TBL] [Abstract][Full Text] [Related]
6. Treatment of choroidal neovascularization using intravitreal bevacizumab. Pedersen R; Soliman W; Lund-Andersen H; Larsen M Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757 [TBL] [Abstract][Full Text] [Related]
7. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections. Melamud A; Stinnett S; Fekrat S Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration at twenty-four months: the Pan-American Collaborative Retina Study. Arevalo JF; Sánchez JG; Wu L; Berrocal MH; Alezzandrini AA; Restrepo N; Maia M; Farah ME; Brito M; Díaz-Llopis M; Rodríguez FJ; Reategui G; Iturralde-Iraola J; Udaondo-Mirete P; Ophthalmology; 2010 Oct; 117(10):1974-81, 1981.e1. PubMed ID: 20569989 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration using a variable frequency regimen in eyes with no previous treatment. Fong KC; Kirkpatrick N; Mohamed Q; Johnston RL Clin Exp Ophthalmol; 2008 Nov; 36(8):748-55. PubMed ID: 19128380 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration. el Matri L; Chebil A; Kort F; Bouraoui R; Baklouti K; Mghaieth F Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):779-84. PubMed ID: 20169357 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy. Rush RB; Rush SW; Aragon AV; Ysasaga JE Am J Ophthalmol; 2014 Aug; 158(2):337-44. PubMed ID: 24844972 [TBL] [Abstract][Full Text] [Related]
12. One-year outcomes of less frequent bevacizumab in age-related macular degeneration. Sonmez K; Sonmez PA; Ozkan SS; Atmaca LS Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration. Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for age-related macular degeneration with good visual acuity. Takahashi M; Sato T; Kishi S Jpn J Ophthalmol; 2010 Nov; 54(6):565-70. PubMed ID: 21191717 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of intravitreal bevacizumab after unresponsive treatment with intravitreal ranibizumab. Almony A; Mansouri A; Shah GK; Blinder KJ Can J Ophthalmol; 2011 Apr; 46(2):182-5. PubMed ID: 21708088 [TBL] [Abstract][Full Text] [Related]